Stress Response to Virtual Risky Movement Exposure and Kinesiophobia After Anterior Cruciate Ligament (ACL) Surgery

NCT ID: NCT05929261

Last Updated: 2023-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

62 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-15

Study Completion Date

2024-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, patients who have completed their rehabilitation after Anterior Cruciate Ligament (ACL) reconstruction surgery will be examined with physiological stress response test while being exposed to risky athletic movements via virtual reality headsets. In the next, step patients' functional performance tests will be examined and their relation with stress responses will be examined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kinesiophobia Anterior Cruciate Ligament Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

Study group will be examined for outcome measurements.

No interventions assigned to this group

Control Group

Control group will be examined for outcome measurements.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Male gender
* Having history of isolated unilateral ACL reconstruction surgery
* Physician clearance for unrestricted physical activity after having at least 6-months of rehabilitation following surgery
* Willing to return to sports that require cutting and landing motions
* Not having any sports injuries past three months
* Not having any previous orthopaedic surgery other than ACL reconstruction surgery


* 18 years or older
* Male gender
* Playing sports that require cutting and landing motions
* Physician clearance for unrestricted physical activity
* Not having any sports injuries past three months
* Not having any previous orthopaedic surgery

Exclusion Criteria

* Having a reinjury during rehabilitation
* Having multiple ligament injuries before the surgery
* Diagnosed with knee osteoarthritis
* Diagnosed with knee cartilage injury
* Diagnosed with meniscus tear


* Diagnosed with ACL injury
* Diagnosed with knee osteoarthritis
* Diagnosed with knee cartilage injury
* Diagnosed with meniscus tear
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ege University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ogun Koyagasioglu

MD, PhD Candidate, Director of the project

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ege University Faculty of Medicine

Izmir, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ogun Koyagasioglu, MD

Role: CONTACT

+90 232 390 23 78

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ogün Köyağasıoğlu

Role: primary

02323902378

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-12.2Tl31

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.